| View |
|
BR-638
|
Methoxy Polyethylene Glycol-Epoetin Beta
|
Mircera
|
50 mcg/0.3 mL
|
Solution for Injection (I.V./S.C.)
|
Prescription Drug (Rx)
|
0.3 mL pre-filled glass syringe + 27 ½" needle per box of 1's. Single Dose.
|
-
|
Roche Diagnostics GmbH
|
Germany
|
For: F. Hoffmann-La Roche Ltd.- Basel, Switzerland
|
Roche (Philippines), Inc.
|
Zuellig Pharma Corporation
|
Automatic Renewal
|
18 September 2021
|
07 October 2026
|
| View |
|
BR-642
|
Methoxy Polyethylene Glycol-Epoetin Beta
|
Mircera
|
200 mcg/0.3 mL
|
Solution for Injection (I.V./S.C.)
|
Prescription Drug (Rx)
|
0.3 mL pre-filled glass syringe + 27 ½" needle per box of 1's. Single Dose.
|
Erythropoiesis Stimulating Agent
|
Roche Diagnostics GmbH
|
Germany
|
For: F. Hoffmann-La Roche Ltd.- Basel, Switzerland
|
Roche (Philippines), Inc.
|
Zuellig Pharma Corporation
|
Automatic Renewal
|
23 September 2021
|
15 September 2026
|
| View |
|
BR-645
|
Epoetin Alfa
|
Epogen
|
4000 IU/mL
|
Solution For Injection (IV/SC)
|
Prescription Drug (RX)
|
1 mL prefilled glass syringe with red push rod and chlorobutyl rubber stopper in blister pack (Box of 1's)
|
Hematopoietic Growth Factors
|
Harbin Pharmaceutical Group Bioengineering Co.,
Ltd.
|
China
|
|
Endure Medical, Inc.
|
Endure Medical, Inc.
|
Renewal
|
20 August 2024
|
08 October 2029
|
| View |
|
BR-647
|
Methoxy Polyethylene Glycol-Epoetin Beta
|
Mircera
|
100 mcg/0.3 mL
|
Solution for Injection (I.V./S.C.)
|
Prescription Drug (Rx)
|
0.3 mL pre-filled glass syringe + 27 ½" needle per box of 1's. Single Dose.
|
Erythropoiesis Stimulating Agent
|
Roche Diagnostics GmbH
|
Germany
|
For: F. Hoffmann-La Roche Ltd.- Basel, Switzerland
|
Roche (Philippines), Inc.
|
Zuellig Pharma Corporation
|
Automatic Renewal
|
23 September 2021
|
15 September 2026
|
| View |
|
BR-651
|
Human Normal Immunoglobulin
|
Ig Vena
|
50mg/mL
|
Solution For Infusion (Iv)
|
Prescription Drug (RX)
|
Clear glass vial x 20mL, 100mL and 200mL (Box of 1's)
|
Immunoglobulin
|
Kedrion S.p.A
|
Italy
|
|
New Marketlink Pharmaceuticals Coporation
|
Metro Drug Inc.
|
Renewal
|
02 November 2023
|
07 November 2028
|
| View |
BR-653_PI_01.pdf
|
BR-653
|
Measles, Mumps, Rubella and Varicella Vaccine (Live,
Attenuated)
|
Priorix-Tetra
|
0.5 mL
|
Powder for Solution for Injection (S.C./1.M.)
|
Prescription Drug (RX)
|
One box contains Type I glass vial + 0.5 mL Type I pre filled glass syringe (Water for Injection as diluent) and two needles.
|
-
|
GlaxoSmithKline Biologicals SA (GSK Biologicals)
|
Belgium
|
|
GlaxoSmithKline Philippines, Inc.
|
GlaxoSmithKline Philippines, Inc.
|
Monitored Release (Variation)
|
11 July 2022
|
11 July 2027
|
| View |
|
BR-663
|
Tetanus Toxoid
|
Bio-Tt
|
10L/f 0.5mL SUSPENSION FOR INJECTOION DEEP S.C./I/M SINGLE USE
|
Deep S.C./I.M. Single Use
|
Prescription Drug (RX)
|
0.5ML CLEAR GLASS AMPOULE PER BOX OF 10'S
|
VACCINE/IMMUNIZATION
|
P.T. Biofarma
|
Indonesia
|
|
Maed Pharma Corporation
|
Maed Pharma Corporation
|
Renewal
|
27 September 2018
|
25 November 2024
|
| View |
|
BR-664
|
Cholera Vaccine (inactivated, oral)
|
OraVacs
|
Formulation Each capsule contains: Inactivated Whole Cell (WC)-5.0 x 10^10 of Vibrio cholerae 01 Inaba, classical biotype (heat inactivated)
Recombinant cholera toxin B subunit (ICTB)--1 mg (produced in V. cholerae 01 Inaba, classical biotype or El Tor biotype)
|
Enteric-Coated Capsule
|
Prescription Drug (RX)
|
Aluminum blister foil (Box of 3's)
|
Vaccines
|
Shanghai United Cell Biotechnology Co., Ltd.
|
China
|
|
ULIVaccines, Inc.
|
GB Distributors Inc.
|
Renewal
|
31 May 2024
|
26 November 2029
|
| View |
|
BR-669
|
Purified Rabies Vaccine (Vero Cell)
|
Speeda
|
2.5 IU
|
Freeze -Dried Powder for Injection (IM/ID)
|
Prescription Drug (RX)
|
5 Clear Glass Vial of Lyophilized Vaccine and 5 (0.5 mL diluent)
ampoules of Water for Injection in plastic tray per box
|
Vaccine
|
Liaoning Cheng Da Biotechnology Co., Ltd.
|
China
|
|
Pharma-Surrey International, Inc.
|
Pharma-Surrey International, Inc.
|
Renewal
|
28 December 2018
|
03 February 2029
|
| View |
|
BR-671
|
Human Normal Immunoglobulin(IGIV)
|
Gamma IV
|
50 mg/mL (2.5 g/50 mL)
|
Solution for IV Injection
|
Prescription Drug (RX)
|
50 mL USP Type I Glass Vial (Box of 1's)
|
Immuoglobulin
|
Bharat Serums and Vaccines Ltd.
|
India
|
|
BSV Bioscience Philippines, Inc.
|
Sandoval Distributors Inc.
|
Renewal
|
30 March 2021
|
10 February 2026
|
| View |
|
BR-673
|
Recombinant Human Thrombopoietin
|
Tpiao
|
15,000 IU/mL
|
Solution for Injection (S.C.)
|
Prescription Drug (Rx)
|
Single dose. Glass vial x 1mL (Box of 1's).
|
Colony-Stimulating Factors
|
Shenyang Sunshine Pharamceutical Co., Ltd.
|
China
|
N/A
|
Goodfellow Pharma Corporation
|
Goodfellow Pharma Corporation
|
Automatic Renewal
|
23 September 2022
|
23 September 2027
|
| View |
|
BR-674
|
Live Attenuated Rotavirus Vaccine
|
Rotarix
|
NLT 106.0 CCID 50/1.5 mL
|
Oral Suspension
|
Prescription Drug (RX)
|
Pre-filled glass syringe x 1.5 mL (Box of l's, 10's and
50's)
|
-
|
GlaxoSmithKline Biologicals S.A.
|
Belgium
|
|
GlaxoSmithKline Philippines, Inc.
|
|
Renewal
|
15 September 2022
|
13 August 2027
|
| View |
|
BR-676
|
Anti-Rabies Serum (Equine)
|
Equirab
|
200 IU/ mL (1,000 IU/ 5mL)
|
Solution for Injection (IM/SC)
|
Prescription Drug (Rx)
|
USP Type I Glass vial x 5mL (Box of 1's)
|
-
|
Bharat Serums and Vaccines Limited
|
India
|
|
NEW MARKETLINK PHARMACEUTICAL CORPORATION
|
NEW MARKETLINK PHARMACEUTICAL CORPORATION
|
-
|
30 March 2021
|
06 March 2026
|
| View |
|
BR-680
|
HEPATITIS B VACCINE (RECOMBINANT DNA )
|
Unbranded
|
20mcg/mL
|
Suspension For Injection (IM)
|
Prescription Drug (RX)
|
Type I clear glass ampoule x 1mL (Box of 1's, 10's and 50's). Single dose.
|
VACCINE
|
Serum Institute of India Ltd.
|
India
|
|
Genpharm Inc.
|
Genpharm Inc.
|
Renewal
|
01 March 2024
|
01 June 2029
|
| View |
BR-689_PI_01.pdf
|
BR-689
|
Tocilizumab
|
Actemra
|
400 mg/ 20 mL
|
Concentrate For Solution For I.V. Infusion
|
Prescription Drug (RX)
|
20 mL colorless Type I glass vial per box
|
Interleukin Inhibitor
|
Chugai Pharma Manufacturing Co., Ltd.
|
Japan
|
|
Roche (Philippines) Inc.
|
Zuellig Pharma Corporation
|
Automatic Renewal
|
10 April 2023
|
20 March 2028
|
| View |
BR-690_PI_01.pdf
|
BR-690
|
Tocilizumab
|
Actemra
|
80 mg/ 4 mL
|
Concentrate For Solution For I.V. Infusion
|
Prescription Drug (RX)
|
20 mL colorless Type I glass vial per box
|
Interleukin Inhibitor
|
Chugai Pharma Manufacturing Co., Ltd.
|
Japan
|
|
Roche (Philippines) Inc.
|
Zuellig Pharma Corporation
|
Automatic Renewal
|
14 April 2023
|
20 March 2028
|
| View |
BR-691_PI_01.pdf
|
BR-691
|
Tocilizumab
|
Actemra
|
200 mg / 10 mL
|
Concentrate For Solution For I.V. Infusion
|
Prescription Drug (RX)
|
20 mL colorless Type I glass vial per box
|
Interleukin Inhibitor
|
Chugai Pharma Manufacturing Co., Ltd.
|
Japan
|
|
Roche (Philippines) Inc.
|
Zuellig Pharma Corporation
|
Automatic Renewal
|
09 April 2023
|
20 March 2028
|
| View |
|
BR-698
|
Filgrastim
|
Recombicyte
|
300mg/0.9mL
|
Solution for Injection (IV/SC)
|
Prescription Drug (RX)
|
0.9 m L Pre-filled Syringe (Box of 1's)
|
-
|
Beijing Four Rings Bio-Pharmaceutical Co., Ltd.
|
China
|
N/A
|
Global Pharmatrade
|
Global Pharmatrade
|
Renewal
|
27 April 2021
|
01 July 2026
|
| View |
|
BR-701
|
Epoetin Alfa
|
Eprex
|
4000 IU/0.4 mL
|
Solution For Injection (IV/SC)
|
Prescription Drug (RX)
|
0.4 mL Solution in a Type I pre-filled glass syringe
fitted with PROTECSTM needle guard (Box of l's)
|
-
|
Cilag AG
|
Switzerland
|
N/A
|
Johnson & Johnson (Philippines), Inc.
|
Zuellig Pharma Corporation
|
-
|
04 February 2022
|
29 July 2026
|
| View |
|
BR-702
|
Epoetin Alfa
|
Eprex
|
10000 IU/mL
|
Solution For Injection (IV/SC)
|
Prescription Drug (RX)
|
1 mL Solution in a Type I pre-filled glass syringe
fitted with PROTECSTM needle guard (Box of l’s)
|
-
|
Cilag AG
|
Switzerland
|
N/A
|
Johnson & Johnson (Philippines), Inc.
|
Zuellig Pharma Corporation
|
-
|
04 February 2022
|
29 July 2026
|